Parathyroid hormone in urinary stone patients
- PMID: 8510669
- DOI: 10.1007/BF00928693
Parathyroid hormone in urinary stone patients
Abstract
To evaluate the role of parathyroids in calculus disease, the parathyroid hormone levels were determined in 22 control subjects and 42 stone (14 with bladder stone and 28 with kidney stone) patients. Serum calcium, inorganic phosphate, alkaline phosphatase and parathyroid hormone and urinary excretion of calcium and inorganic phosphate were determined. It was found that normocalcemic and normocalciuric stone patients had slightly higher levels of parathyroid hormone (irrespective of the site of the stone) and the difference was not statistically significant as compared with control subjects although some of the patients with calculus disease were hyperparathyroid. Serum alkaline phosphatase was increased while there was an increase in urinary calcium excretion in kidney stone patients and oxalate in all patients as compared with control subjects. The increase in inorganic phosphate was, however, not different from the control subjects. The subclinical hyperparathyroidism and stone formation in these patients are not correlated.
Similar articles
-
An assessment of parathyroid hormone, calcitonin, 1,25 (OH)2 vitamin D3, estradiol and testosterone in men with active calcium stone disease and evaluation of its biochemical risk factors.Urol Res. 2011 Feb;39(1):1-7. doi: 10.1007/s00240-010-0276-3. Epub 2010 May 19. Urol Res. 2011. PMID: 20490785
-
Parathyroid hormone is normal in renal stone patients with idiopathic hypercalciuria and high fasting urinary calcium.Urol Res. 1982;10(4):205-7. doi: 10.1007/BF00255945. Urol Res. 1982. PMID: 7179613
-
[Evaluation of renal cyclic adenosine monophosphate, serum parathyroid hormone and phosphate reabsorption in recurrent calcium urolithiasis, healthy controls and hyperparathyroidism (author's transl)].Klin Wochenschr. 1978 Jun 15;56(12):601-6. doi: 10.1007/BF01477008. Klin Wochenschr. 1978. PMID: 210311 German.
-
Hyperparathyroidism.N Engl J Med. 1969 Aug 14;281(7):367-74. doi: 10.1056/NEJM196908142810708. N Engl J Med. 1969. PMID: 4893704 Review. No abstract available.
-
Oxalate metabolism in renal stone disease with special reference to calcium metabolism and intestinal absorption.Scand J Urol Nephrol Suppl. 1989;119:1-53. Scand J Urol Nephrol Suppl. 1989. PMID: 2669121 Review.
Cited by
-
An assessment of parathyroid hormone, calcitonin, 1,25 (OH)2 vitamin D3, estradiol and testosterone in men with active calcium stone disease and evaluation of its biochemical risk factors.Urol Res. 2011 Feb;39(1):1-7. doi: 10.1007/s00240-010-0276-3. Epub 2010 May 19. Urol Res. 2011. PMID: 20490785
-
Associations between 25-hydroxyvitamin D/calcium/alkaline phosphatase levels and the risk of developing kidney stones: Results from NHANES (2013-2018)-based and Mendelian randomization studies.Medicine (Baltimore). 2025 Jan 24;104(4):e41323. doi: 10.1097/MD.0000000000041323. Medicine (Baltimore). 2025. PMID: 39854758 Free PMC article.
-
Hypercalcemic States associated with nephrolithiasis.Rev Urol. 2008 Summer;10(3):218-26. Rev Urol. 2008. PMID: 18836558 Free PMC article.